| 2026-08-04 | Press release | Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognos |
| 2026-07-30 | Press release | Tempus Reports Second Quarter 2026 Results |
| 2026-07-22 | Press release | Tempus Announces National Launch of OneOme Pharmacogenomics Testing, Advancing Patient Safety and Precision Medicine |
| 2026-07-20 | Press release | Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision On |
| 2026-07-09 | Press release | Tempus to Report Second Quarter 2026 Financial Results on July 30 |
| 2026-06-25 | Press release | Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers |
| 2026-06-11 | Press release | Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in He |
| 2026-06-05 | Press release | Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference |
| 2026-06-03 | Press release | Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Found |
| 2026-05-29 | Press release | Tempus Receives FDA Approval for Tumor Only xT CDx, Enabling Migration of its Entire DNA Solid Tumor Portfolio |
| 2026-05-29 | Press release | Tempus Announces Initial Results from its Multimodal Foundation Model Efforts for Novel and Scalable Insight Generation |
| 2026-05-14 | Press release | Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical D |
| 2026-04-29 | Press release | Tempus to Host Inaugural Investor Day on May 29, 2026 |
| 2026-04-23 | Press release | Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine |
| 2026-04-15 | Press release | Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Seq |
| 2026-04-09 | Press release | Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE |
| 2026-04-08 | Press release | Tempus to Present at the 25th Annual Needham Virtual Healthcare Conference |
| 2026-04-01 | Press release | Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant |
| 2026-03-17 | Press release | Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Re |
| 2026-03-11 | Press release | Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable |
| 2026-03-03 | Press release | Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine |
| 2026-02-26 | Press release | Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference |
| 2026-02-12 | Press release | Tempus Announces Collaboration with Median Technologies to Integrate AI-Powered Lung Cancer Screening into the Pixel Pla |
| 2026-01-27 | Press release | Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional Biomarkers |
| 2026-01-12 | Press release | Tempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology |
| 2026-01-12 | Press release | Northwestern Medicine Selects Tempus to Expand Genomic Testing |
| 2026-01-08 | Press release | Tempus Announces Eight Abstracts Accepted for Presentation at the 2026 ASCO® Gastrointestinal Cancers Symposium |
| 2026-01-06 | Press release | Tempus to Present at 44th Annual J.P. Morgan Healthcare Conference |
| 2025-02-24 | Press release | Q4 2024 Results |
| 2025-01-13 | Presentation | J.P. Morgan Healthcare Conference 2025 Presentation |
| 2024-11-04 | Quarterly report | Q3 2024 Overview |
| 2024-11-04 | Press release | Q3 2024 Results |
| 2024-08-06 | Press release | Q2 2024 Results |
| Press release | Tempus xF Liquid Biopsy Assay Demonstrates Extensive Analytical and Clinical Validity in npj Precision Oncology Study |
| Press release | Tempus Welcomes UNC Lineberger Comprehensive Cancer Center to Tempus+ Community |
| Press release | Tempus Welcomes Rush University Medical Center to Tempus+ Community |
| Press release | Tempus Welcomes City of Hope Comprehensive Cancer Center to Tempus+ Community |
| Press release | Tempus Unveils Its Scalable Tumor Organoid Screening Platform In Cell Reports Study |
| Press release | Tempus Submits PMA Application to the FDA for its xT-Onco Assay |
| Press release | Tempus Signs Strategic Collaboration Agreement with AstraZeneca to Advance Oncology Therapeutics |